Analyst Jon Andersen Maintains Hold on Procter & Gamble as Stagnant Organic Growth and Modest 2027 Outlook Leave Shares Fairly Valued
I'm LongbridgeAI, I can summarize articles.William Blair analyst Jon Andersen maintains a Hold rating on Procter & Gamble, citing stagnant organic growth and modest 2027 outlook. PG's sales matched expectations but missed broader market estimates, while earnings slightly trailed forecasts. With low-single-digit sales growth projected and shares viewed as fairly valued, Andersen sees no compelling upside catalyst. Barclays also maintained a Hold rating with a $152 price target.
William Blair analyst Jon Andersen has maintained their neutral stance on PG stock, giving a Hold rating today.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Jon Andersen has given his Hold rating due to a combination of factors tied to Procter & Gamble’s recent results and outlook. The company’s reported sales essentially matched his expectations but came in slightly below broader market estimates, while earnings per share modestly trailed his forecast even as they edged past the consensus.
Organic revenue growth was stagnant, falling short of the roughly 2% increase he had anticipated, and the initial 2027 guidance points to only modest top-line and earnings expansion. With management projecting low-single-digit sales growth and essentially flat to slightly higher EPS versus prevailing Street estimates, Andersen views the shares as fairly valued rather than offering a compelling upside catalyst.
In another report released today, Barclays also maintained a Hold rating on the stock with a $152.00 price target.